Patents by Inventor Meghan E. CASEY

Meghan E. CASEY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Taurine supplemented cell culture medium and methods of use
    Patent number: 12577528
    Abstract: The specification describes a composition comprising an improved eukaryotic cell culture medium, which can be used for the production of a protein of interest. Taurine can be added to the serum-free media or chemically-defined media to increase the production of a protein of interest. Methods for recombinantly expressing high levels of protein using the media compositions are included.
    Type: Grant
    Filed: March 29, 2022
    Date of Patent: March 17, 2026
    Assignee: Regeneron Pharmaceuticals, Inc.
    Inventors: Amy S. Johnson, Meghan E. Casey, Shadia Oshodi, Shawn M. Lawrence
  • TAURINE SUPPLEMENTED CELL CULTURE MEDIUM AND METHODS OF USE
    Publication number: 20250340832
    Abstract: The specification describes a composition comprising an improved eukaryotic cell culture medium, which can be used for the production of a protein of interest. TaXULne can be added to the serum-free media or chemically-defined media to increase the production of a protein of interest. Methods for recombinantly expressing high levels of protein using the media compositions are included.
    Type: Application
    Filed: July 15, 2025
    Publication date: November 6, 2025
    Inventors: Amy S. Johnson, Meghan E. Casey, Shadia Oshodi, Shawn Lawrence
  • TAURINE SUPPLEMENTED CELL CULTURE MEDIUM AND METHODS OF USE
    Publication number: 20250327023
    Abstract: The specification describes a composition comprising an improved eukaryotic cell culture medium, which can be used for the production of a protein of interest. TaXULne can be added to the serum-free media or chemically-defined media to increase the production of a protein of interest. Methods for recombinantly expressing high levels of protein using the media compositions are included.
    Type: Application
    Filed: June 5, 2025
    Publication date: October 23, 2025
    Inventors: Amy S. Johnson, Meghan E. Casey, Shadia Oshodi, Shawn Lawrence
  • Taurine supplemented cell culture medium and methods of use
    Patent number: 12359165
    Abstract: The specification describes a composition comprising an improved eukaryotic cell culture medium, which can be used for the production of a protein of interest. TaXULne can be added to the serum-free media or chemically-defined media to increase the production of a protein of interest. Methods for recombinantly expressing high levels of protein using the media compositions are included.
    Type: Grant
    Filed: May 23, 2024
    Date of Patent: July 15, 2025
    Assignee: Regeneron Pharmaceuticals, Inc.
    Inventors: Amy S. Johnson, Meghan E. Casey, Shadia Oshodi, Shawn Lawrence
  • Taurine supplemented cell culture medium and methods of use
    Patent number: 12359166
    Abstract: The specification describes a composition comprising an improved eukaryotic cell culture medium, which can be used for the production of a protein of interest. TaXULne can be added to the serum-free media or chemically-defined media to increase the production of a protein of interest. Methods for recombinantly expressing high levels of protein using the media compositions are included.
    Type: Grant
    Filed: May 23, 2024
    Date of Patent: July 15, 2025
    Assignee: Regeneron Pharmaceuticals, Inc.
    Inventors: Amy S. Johnson, Meghan E. Casey, Shadia Oshodi, Shawn Lawrence
  • Taurine supplemented cell culture medium and methods of use
    Patent number: 12221619
    Abstract: The specification describes a composition comprising an improved eukaryotic cell culture medium, which can be used for the production of a protein of interest. TaXULne can be added to the serum-free media or chemically-defined media to increase the production of a protein of interest. Methods for recombinantly expressing high levels of protein using the media compositions are included.
    Type: Grant
    Filed: September 22, 2023
    Date of Patent: February 11, 2025
    Assignee: Regeneron Pharmaceuticals Inc.
    Inventors: Amy S. Johnson, Meghan E. Casey, Shadia Oshodi, Shawn Lawrence
  • TAURINE SUPPLEMENTED CELL CULTURE MEDIUM AND METHODS OF USE
    Publication number: 20240309315
    Abstract: The specification describes a composition comprising an improved eukaryotic cell culture medium, which can be used for the production of a protein of interest. TaXULne can be added to the serum-free media or chemically-defined media to increase the production of a protein of interest. Methods for recombinantly expressing high levels of protein using the media compositions are included.
    Type: Application
    Filed: May 23, 2024
    Publication date: September 19, 2024
    Inventors: Amy S. Johnson, Meghan E. Casey, Shadia Oshodi, Shawn Lawrence
  • TAURINE SUPPLEMENTED CELL CULTURE MEDIUM AND METHODS OF USE
    Publication number: 20240309316
    Abstract: The specification describes a composition comprising an improved eukaryotic cell culture medium, which can be used for the production of a protein of interest. TaXULne can be added to the serum-free media or chemically-defined media to increase the production of a protein of interest. Methods for recombinantly expressing high levels of protein using the media compositions are included.
    Type: Application
    Filed: May 23, 2024
    Publication date: September 19, 2024
    Inventors: Amy S. Johnson, Meghan E. Casey, Shadia Oshodi, Shawn Lawrence
  • TAURINE SUPPLEMENTED CELL CULTURE MEDIUM AND METHODS OF USE
    Publication number: 20240018467
    Abstract: The specification describes a composition comprising an improved eukaryotic cell culture medium, which can be used for the production of a protein of interest. TaXULne can be added to the serum-free media or chemically-defined media to incrase the production of a protein of interest. Methods for recombinantly expressing high levels of protein using the media compositions are included.
    Type: Application
    Filed: September 22, 2023
    Publication date: January 18, 2024
    Inventors: Amy S. Johnson, Meghan E. Casey, Shadia Oshodi, Shawn Lawrence
  • Anti-VEGF protein compositions and methods for producing the same
    Patent number: 11753459
    Abstract: The present disclosure pertains to compositions comprising anti-VEGF proteins.
    Type: Grant
    Filed: July 6, 2022
    Date of Patent: September 12, 2023
    Assignee: Regeneron Pharmaceuticals, Inc.
    Inventors: Shunhai Wang, Ning Li, Hunter Chen, Amardeep Singh Bhupender Bhalla, Shawn M. Lawrence, Amy S. Johnson, Meghan E. Casey, Jaimie Grapel
  • TAURINE SUPPLEMENTED CELL CULTURE MEDIUM AND METHODS OF USE
    Publication number: 20220235318
    Abstract: The specification describes a composition comprising an improved eukaryotic cell culture medium, which can be used for the production of a protein of interest. Taurine can be added to the serum-free media or chemically-defined media to increase the production of a protein of interest. Methods for recombinantly expressing high levels of protein using the media compositions are included.
    Type: Application
    Filed: March 29, 2022
    Publication date: July 28, 2022
    Inventors: Amy S. JOHNSON, Meghan E. CASEY, Shadia OSHODI, Shawn M. LAWRENCE
  • Taurine supplemented cell culture medium and methods of use
    Patent number: 11312936
    Abstract: The specification describes a composition comprising an improved eukaryotic cell culture medium, which can be used for the production of a protein of interest. Taurine can be added to serum-free media or chemically-defined media to increase the production of a protein of interest. Methods for recombinantly expressing high levels of protein using the media compositions are included.
    Type: Grant
    Filed: August 3, 2016
    Date of Patent: April 26, 2022
    Assignee: Regeneron Pharmaceuticals, Inc.
    Inventors: Amy S. Johnson, Meghan E. Casey, Shadia Oshodi, Shawn Lawrence
  • Taurine supplemented cell culture medium and methods of use
    Patent number: 10927342
    Abstract: The specification describes a composition comprising an improved eukaryotic cell culture medium, which can be used for the production of a protein of interest. Taurine can be added to the serum-free media or chemically-defined media to increase the production of a protein of interest. Methods for recombinantly expressing high levels of protein using the media compositions are included.
    Type: Grant
    Filed: January 14, 2020
    Date of Patent: February 23, 2021
    Assignee: Regeneran Pharmaceuticals, Inc.
    Inventors: Amy S. Johnson, Meghan E. Casey, Shadia Oshodi, Shawn Lawrence
  • TAURINE SUPPLEMENTED CELL CULTURE MEDIUM AND METHODS OF USE
    Publication number: 20200157492
    Abstract: The specification describes a composition comprising an improved eukaryotic cell culture medium, which can be used for the production of a protein of interest. Taurine can be added to the serum-free media or chemically-defined media to increase the production of a protein of interest. Methods for recombinantly expressing high levels of protein using the media compositions are included.
    Type: Application
    Filed: January 14, 2020
    Publication date: May 21, 2020
    Inventors: Amy S. JOHNSON, Meghan E. CASEY, Shadia OSHODI, Shawn LAWRENCE
  • TAURINE SUPPLEMENTED CELL CULTURE MEDIUM AND METHODS OF USE
    Publication number: 20180223249
    Abstract: The specification describes a composition comprising an improved eukaryotic cell culture medium, which can be used for the production of a protein of interest. Taurine can be added to serum-free media or chemically-defined media to increase the production of a protein of interest. Methods for recombinantly expressing high levels of protein using the media compositions are included.
    Type: Application
    Filed: August 3, 2016
    Publication date: August 9, 2018
    Applicant: Regeneron Pharmaceuticals, Inc.
    Inventors: Amy S. JOHNSON, Meghan E. CASEY, Shadia OSHODI, Shawn LAWRENCE